NCT02840513 (SMART-CO) is a Phase 4 clinical trial of Smartphone app/CO self-monitoring in Smoking, sponsored by Alain Nordmann.

Who is sponsoring NCT02840513?

NCT02840513 is sponsored by Alain Nordmann.

What drugs are being tested in NCT02840513?

Interventions in NCT02840513: Smartphone app/CO self-monitoring.

What condition does NCT02840513 study?

NCT02840513 studies Smoking, HIV.

Is NCT02840513 still recruiting?

NCT02840513 is currently terminated. Last updated 10 July 2020.

Last reviewed 2020-07-10 · How we verify

NCT02840513: SMART-CO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Smartphone App and CO Self-monitoring for Smoking Cessation

Terminated Phase 4 Last updated 10 July 2020

What this trial tests

Phase 4 trial testing Smartphone app/CO self-monitoring in Smoking in 81 participants. Terminated before completion.

Timeline

1 June 2017

Primary endpoint
24 June 2019

24 June 2019

Quick facts

Lead sponsor	Alain Nordmann
Phase	Phase 4
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	81
Start date	1 June 2017
Primary completion	24 June 2019
Estimated completion	24 June 2019
Sites	1 location across Switzerland

Drugs / interventions tested

Smartphone app/CO self-monitoring

Conditions studied

Smoking — all drugs for Smoking →
HIV — all drugs for HIV →

Sponsor

Alain Nordmann

Who can join

16 and older, any sex, with Smoking or HIV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial is going to evaluate whether an intervention consisting of a smartphone application to assist smokers living with HIV to quit in combination with CO self-monitoring compared to stop smoking counselling by physicians during usual care results in higher self-reported and biochemically verified smoking cessation rates at 6 months. .

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Mobile phone text messaging and app-based interventions for smoking cessation.
Whittaker R, McRobbie H, Bullen C, Rodgers A, et al · · 2019 · cited 278× · PMID 31638271 · DOI 10.1002/14651858.cd006611.pub5
Biomedical risk assessment as an aid for smoking cessation.
Clair C, Mueller Y, Livingstone-Banks J, Burnand B, et al · · 2019 · cited 20× · PMID 30912847 · DOI 10.1002/14651858.cd004705.pub5
Interventions for tobacco use cessation in people living with HIV.
Mdege ND, Shah S, Dogar O, Pool ER, et al · · 2024 · cited 6× · PMID 39101506 · DOI 10.1002/14651858.cd011120.pub3

Verify or expand the search:

Other recruiting trials for Smoking

Currently open trials in the same condition.

NCT07488741 — Comparison of the Effects of Different Chest Techniques on University Students With Smoking Addiction · NA · recruiting
NCT07443631 — Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants · NA · recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products · NA · recruiting
NCT06966258 — Inspire HER: Inspiring the Heart and Emotions for Radical Health · NA · recruiting
NCT06713603 — Technology Assisted Motivational Interviewing · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02840513 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alain Nordmann
Last refreshed: 10 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02840513.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing